Tarsa Therapeutics Announces Addition of Senior Level Clinical and Regulatory Expertise

PHILADELPHIA, Feb. 18 PRNewswire -- Tarsa Therapeutics, Inc. today announced the addition of two executives to its senior management team. David Krause, M.D., F.A.C.P., has joined as Chief Medical Officer and Thomas C. Wicks, Ph.D., has joined as Vice President Global Regulatory...

Aton Pharma Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations

LAWRENCEVILLE, N.J., Feb. 16 /PRNewswire/ -- Aton Pharma, Inc., a diversified specialty pharmaceutical company, announced today that Wayne S. Mulcahy, Ph.D., has joined the company as Vice President, Clinical Operations. A wholly owned subsidiary of Princeton Pharma Holdings LLC, Aton is focused on the development and commercialization of unique products in ophthalmology and orphan...

Icahn, Whitworth Boosted Stakes in Drugmaker Genzyme During Fourth Quarter

Activist investors Carl Icahn and Ralph Whitworth raised their stakes in Genzyme...

SLU hires laid-off Pfizerites for research center

When Pfizer refocused its ops in November, it left about 600 of its 1,000 employees in the St. Louis area without a job. But St. Louis University doesn't want to see that talent go to waste. Some of those scientists may find a home at the school, which announced that it's launching a new research center focused on discovering treatments for illnesses that affect the developing...

Dr. Carol Moreno-Quinn Joins PhysioGenix’s Science Advisory Team

Milwaukee, WI (PRWEB) January 27, 2010 — Physiogenix, Inc., www.physiogenix.com, a world-leader in research services and solutions in the field of chronic disease, today announced that Dr. Carol Moreno-Quinn, M.D., Ph.D. will collaborate with the Company as a study director. Dr. Moreno-Quinn has extensive research experience in the fields of genetics, renal and cardiovascular diseases. Dr. Moreno-Quinn has spent five years as an Assistant Professor at the Medical College of Wisconsin. At the...

Joe Jimenez to replace Daniel Vasella as Novartis CEO

> Joe Jimenez to replace Daniel Vasella as Novartis CEO. Release > Afferent Pharmaceuticals has appointed Bruce McCarthy as CEO. Release > Pavan Handa has joined Antares Pharma as SVP of business development....

HistoRx Names Dick Carroll, Ph.D. as VP of Clinical Research

NEW HAVEN, Conn., Jan. 19 /PRNewswire/ -- HistoRx, Inc. announced today that it has appointed Dr. Richard J. Carroll to the newly created position of Vice President, Clinical Research. Dr. Carroll brings to HistoRx over 20 years of sales, marketing, research, and general management experience in...